The present disclosure pertains to medical devices, and methods for manufacturing and/or using medical devices. More particularly, the present disclosure pertains to leadless cardiac devices and methods, such as leadless cardiac pacing devices and methods, and delivery and retrieval devices and methods for such leadless devices.
A wide variety of medical devices have been developed for medical use, for example, cardiac use. Some of these devices include catheters, leads, pacemakers, and the like, and delivery devices and/or systems used for delivering such devices. These devices are manufactured by any one of a variety of different manufacturing methods and may be used according to any one of a variety of methods. Of the known medical devices, delivery systems, and methods, each has certain advantages and disadvantages. There is an ongoing need to provide alternative medical devices and delivery devices as well as alternative methods for manufacturing and using medical devices and delivery devices.
In one example, an implantation and/or retrieval device for a leadless cardiac pacing device may comprise: a first elongate shaft including a lumen; a second elongate shaft slidably disposed within the lumen of the first elongate shaft; an end cap assembly fixedly attached to a distal end of the first elongate shaft; and a plurality of wires attached to the second elongate shaft and extending distally from the end cap assembly, the plurality of wires being movable relative to the end cap assembly. The plurality of wires is configured to engage a proximal hub of the leadless cardiac pacing device. The plurality of wires forms a plurality of wire loops extending distally from the end cap assembly.
In addition or alternatively, the end cap assembly includes an insert secured within an outer housing, the outer housing being fixedly attached to the distal end of the first elongate shaft.
In addition or alternatively, a distalmost surface of the insert is flush with a distalmost end surface of the outer housing.
In addition or alternatively, the insert includes a plurality of bores extending through the insert, wherein the plurality of bores is configured to receive the plurality of wires.
In addition or alternatively, each of the plurality of bores curves radially outwardly in a distal direction.
In addition or alternatively, the insert is a unitary structure.
In addition or alternatively, the insert comprises a plurality of insert members, each insert member including at least a portion of one or more of the plurality of bores extending through the insert member.
In addition or alternatively, each of the plurality of bores is configured to receive more than one of the plurality of wires.
In addition or alternatively, circumferentially adjacent wire loops of the plurality of wire loops crisscross each other when viewed axially.
In addition or alternatively, an implantation and/or retrieval device for a leadless cardiac pacing device may comprise: a first elongate shaft including a lumen; an end cap assembly fixedly attached to a distal end of the first elongate shaft; and a plurality of wires extending through the end cap assembly and forming a plurality of wire loops distal of the end cap assembly, the plurality of wires being movable through the end cap assembly between a first position and a second position distal of the first position. The plurality of wire loops is configured to secure the proximal hub of the leadless cardiac pacing device relative to the end cap assembly in the first position.
In addition or alternatively, the end cap assembly includes an insert secured within an outer housing. The insert may include a distalmost surface that is flush with a distalmost surface of the outer housing, and a plurality of bores extending through the insert and opening distally. The plurality of wire loops is configured to secure the proximal hub of the leadless cardiac pacing device against the distalmost surface of the insert in the first position.
In addition or alternatively, circumferentially adjacent wire loops of the plurality of wire loops crisscross each other when viewed axially.
In addition or alternatively, the plurality of wires is configured to transfer rotational motion of the first elongate shaft to the proximal hub in the first position.
In addition or alternatively, the plurality of wire loops includes a first wire loop passing through a first pair of the plurality of bores, a second wire loop passing through a second pair of the plurality of bores, and a third wire loop passing through a third pair of the plurality of bores.
In addition or alternatively, one of the second pair of the plurality of bores is disposed circumferentially between the first pair of the plurality of bores, and one of the third pair of the plurality of bores is disposed circumferentially between the second pair of the plurality of bores.
In addition or alternatively, a distal end segment of the first wire loop is parallel to a distal end segment of the third wire loop, and the distal end segment of the first wire loop is perpendicular to a distal end segment of the second wire loop.
In addition or alternatively, system may comprise: a leadless cardiac pacing device including a body, a proximal hub, and a helical fixation member opposite the proximal hub; a catheter; a first elongate shaft slidably disposed within the catheter, the first elongate shaft including a lumen and a proximal handle; a second elongate shaft slidably disposed within the lumen of the first elongate shaft; an end cap assembly including an outer housing fixedly attached to a distal end of the first elongate shaft and an insert secured within the outer housing; and a plurality of wires fixedly attached to the second elongate shaft and extending distally from the end cap assembly to form a plurality of wire loops translatable between a first position and a second position distal of the first position. The plurality of wire loops is configured to engage the proximal hub of the leadless cardiac pacing device in the first position.
In addition or alternatively, the end cap assembly is devoid of any structure configured to engage a side surface of the proximal hub.
In addition or alternatively, the plurality of wires is configured to transfer rotational motion of the first elongate shaft to the proximal hub in the first position.
In addition or alternatively, the leadless cardiac pacing device includes a neck portion extending longitudinally from the body to the proximal hub. In the first position, the plurality of wire loops includes three or more intersecting distal end segments forming a bounded opening receiving the neck portion therethrough.
The above summary of some embodiments, aspects, and/or examples is not intended to describe each embodiment or every implementation of the present disclosure. The figures and the detailed description which follows more particularly exemplify these embodiments.
The disclosure may be more completely understood in consideration of the following detailed description in connection with the accompanying drawings, in which:
While the disclosure is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit aspects of the disclosure to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the disclosure.
The following description should be read with reference to the drawings, which are not necessarily to scale, wherein like reference numerals indicate like elements throughout the several views. The detailed description and drawings are intended to illustrate but not limit the claimed invention. Those skilled in the art will recognize that the various elements described and/or shown may be arranged in various combinations and configurations without departing from the scope of the disclosure. The detailed description and drawings illustrate example embodiments of the claimed invention. However, in the interest of clarity and ease of understanding, while every feature and/or element may not be shown in each drawing, the feature(s) and/or element(s) may be understood to be present regardless, unless otherwise specified.
For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification.
All numeric values are herein assumed to be modified by the term “about,” whether or not explicitly indicated. The term “about”, in the context of numeric values, generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (e.g., having the same function or result). In many instances, the term “about” may include numbers that are rounded to the nearest significant figure. Other uses of the term “about” (e.g., in a context other than numeric values) may be assumed to have their ordinary and customary definition(s), as understood from and consistent with the context of the specification, unless otherwise specified.
The recitation of numerical ranges by endpoints includes all numbers within that range, including the endpoints (e.g., 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).
Although some suitable dimensions, ranges, and/or values pertaining to various components, features and/or specifications are disclosed, one of skill in the art, incited by the present disclosure, would understand desired dimensions, ranges, and/or values may deviate from those expressly disclosed.
As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise. It is to be noted that in order to facilitate understanding, certain features of the disclosure may be described in the singular, even though those features may be plural or recurring within the disclosed embodiment(s). Each instance of the features may include and/or be encompassed by the singular disclosure(s), unless expressly stated to the contrary. For simplicity and clarity purposes, not all elements of the disclosed invention are necessarily shown in each figure or discussed in detail below. However, it will be understood that the following discussion may apply equally to any and/or all of the components for which there are more than one, unless explicitly stated to the contrary. Additionally, not all instances of some elements or features may be shown in each figure for clarity.
Relative terms such as “proximal”, “distal”, “advance”, “retract”, variants thereof, and the like, may be generally considered with respect to the positioning, direction, and/or operation of various elements relative to a user/operator/manipulator of the device, wherein “proximal” and “retract” indicate or refer to closer to or toward the user and “distal” and “advance” indicate or refer to farther from or away from the user. In some instances, the terms “proximal” and “distal” may be arbitrarily assigned in an effort to facilitate understanding of the disclosure, and such instances will be readily apparent to the skilled artisan. Other relative terms, such as “upstream”, “downstream”, “inflow”, and “outflow” refer to a direction of fluid flow within a lumen, such as a body lumen, a blood vessel, or within a device.
The term “extent” may be understood to mean a greatest measurement of a stated or identified dimension, unless the extent or dimension in question is preceded by or identified as a “minimum”, which may be understood to mean a smallest measurement of the stated or identified dimension. For example, “outer extent” may be understood to mean an outer dimension, “radial extent” may be understood to mean a radial dimension, “longitudinal extent” may be understood to mean a longitudinal dimension, etc. Each instance of an “extent” may be different (e.g., axial, longitudinal, lateral, radial, circumferential, etc.) and will be apparent to the skilled person from the context of the individual usage. Generally, an “extent” may be considered a greatest possible dimension measured according to the intended usage, while a “minimum extent” may be considered a smallest possible dimension measured according to the intended usage. In some instances, an “extent” may generally be measured orthogonally within a plane and/or cross-section, but may be, as will be apparent from the particular context, measured differently—such as, but not limited to, angularly, radially, circumferentially (e.g., along an arc), etc.
The terms “monolithic” and “unitary” shall generally refer to an element or elements made from or consisting of a single structure or base unit/element. A monolithic and/or unitary element shall exclude structure and/or features made by assembling or otherwise joining multiple discrete elements together.
It is noted that references in the specification to “an embodiment”, “some embodiments”, “other embodiments”, etc., indicate that the embodiment(s) described may include a particular feature, structure, or characteristic, but every embodiment may not necessarily include the particular feature, structure, or characteristic. Moreover, such phrases are not necessarily referring to the same embodiment. Further, when a particular feature, structure, or characteristic is described in connection with an embodiment, it would be within the knowledge of one skilled in the art to effect the particular feature, structure, or characteristic in connection with other embodiments, whether or not explicitly described, unless clearly stated to the contrary. That is, the various individual elements described below, even if not explicitly shown in a particular combination, are nevertheless contemplated as being combinable or arrangeable with each other to form other additional embodiments or to complement and/or enrich the described embodiment(s), as would be understood by one of ordinary skill in the art.
For the purpose of clarity, certain identifying numerical nomenclature (e.g., first, second, third, fourth, etc.) may be used throughout the description and/or claims to name and/or differentiate between various described and/or claimed features. It is to be understood that the numerical nomenclature is not intended to be limiting and is exemplary only. In some embodiments, alterations of and deviations from previously-used numerical nomenclature may be made in the interest of brevity and clarity. That is, a feature identified as a “first” element may later be referred to as a “second” element, a “third” element, etc. or may be omitted entirely, and/or a different feature may be referred to as the “first” element. The meaning and/or designation in each instance will be apparent to the skilled practitioner.
Cardiac pacemakers provide electrical stimulation to heart tissue to cause the heart to contract and thus pump blood through the vascular system. Conventional pacemakers typically include an electrical lead that extends from a pulse generator implanted subcutaneously or sub-muscularly to an electrode positioned adjacent the inside or outside wall of the cardiac chamber. As an alternative to conventional pacemakers, self-contained or leadless cardiac pacemakers have been proposed. Leadless cardiac pacemakers are small capsules typically fixed to an intracardiac implant site in or around a cardiac chamber. The small capsule typically includes bipolar pacing/sensing electrodes, a power source (e.g., a battery), and associated electrical circuitry for controlling the pacing/sensing electrodes, and thus provide electrical stimulation to heart tissue and/or sense a physiological condition. In some cases, the leadless cardiac pacemakers may include a proximal and/or a distal extension extending from the small capsule, where the extension(s) may include one or more pacing/sensing electrodes. The capsule may be delivered to the heart using a delivery device which may be advanced through a femoral vein, into the inferior vena cava, into the right atrium, and into the coronary sinus and vessels extending through and/or to the coronary sinus. Accordingly, it may be desirable to provide cardiac pacing devices and delivery devices which facilitate advancement through the vasculature.
The leadless cardiac pacing device described herein may detect and treat cardiac arrhythmias, and more particularly, deliver electrical stimulation therapy to a right atrium, left atrium, right ventricle, and/or a left ventricle of a heart of a patient. For instance, one or more devices may be implanted on or within a patient's heart, and the one or more devices may be configured to deliver electrical stimulation therapy to one or more chambers of the patient's heart in accordance with one or more therapy programs and/or to treat one or more types of detected cardiac arrhythmias. Some example electrical stimulation therapies include bradycardia therapy, cardiac resynchronization therapy (CRT), anti-tachycardia pacing (ATP) therapy, defibrillation and/or cardioversion therapy, and the like. Some example cardiac arrhythmias include atrial fibrillation or atrial flutter, ventricular fibrillation, and tachycardia.
Although various features of a leadless cardiac pacing device are described herein, alternative and/or additional features of an example leadless cardiac pacing device are discussed in U.S. Provisional Patent Application Ser. No. 62/826,496 entitled SYSTEMS AND METHODS FOR TREATING CARDIAC ARRHYTHMIAS filed on Mar. 29, 2019, which is hereby incorporated by reference for all purposes; and U.S. Provisional Patent Application Ser. No. 62/826,507 entitled SYSTEMS AND METHODS FOR TREATING CARDIAC ARRHYTHMIAS filed on Mar. 29, 2019, which is hereby incorporated by reference for all purposes. Hereinafter, these references incorporated by reference are referred to as the “references incorporated herein”.
In the example of
The body 22 may have any dimension suitable for implantation at a target location within the heart 10 of a patient. In one example, the body 22 may have a cross-sectional diameter or area sufficient to fit within the coronary sinus 15, which may vary between about 0.24 inches (6 mm) to about 0.6 inches (15 mm). A diameter of the body 22 may range, in different embodiments, between about 0.1 inches (2.54 mm) to about 0.4 inches (10 mm). The body 22 may be sized to be implanted within different sized coronary sinuses while still allowing sufficient blood flow through the coronary sinus 15.
In some embodiments, the leadless cardiac pacing device 20 may include one or more electrodes. In one example, the body 22 of the leadless cardiac pacing device 20 may support a first electrode 26 and a second electrode 28, while the distal extension 24 may support a distal electrode. In some cases, the distal extension 24 may include a plurality of electrodes (e.g., a first proximal ring electrode 30, a second proximal ring electrode 32, a third proximal ring electrode 34, a distal ring electrode 36, and/or one or more other electrodes). Although the electrodes described may be indicated as being ring electrodes, other electrode types may be utilized depending on the application.
In some cases, the first electrode 26 may be formed on, along, and/or from the body 22 and the second electrode 28 may be formed on, along, and/or from a fixation member 50 (discussed in greater detail below) extending from the body 22. In one example, the body 22 may be at least partially formed from an electrically conductive material and an exposed surface of such electrically conductive material may form, at least in part, the first electrode 26. Additionally, or alternatively, the second electrode 28 may be formed from one or more exposed electrically conductive surface portions of the fixation member 50 that may be exposed to cardiac tissue of the patient. Various arrangements for the electrodes 26, 28, including location, shape, material(s), etc. are contemplated. Alternative and/or additional electrode configurations for a leadless cardiac pacing device 20 are discussed in the references incorporated herein.
When provided, the electrodes of the leadless cardiac pacing device 20 may be used to deliver electrical stimulation to heart 10, and/or sense one or more physiologic signals. In some cases, the leadless cardiac pacing device 20 may use one or more of the electrodes (e.g., electrodes 26-36 or other electrodes) to communicate with one or more other devices, such as, but not limited to, one or more other leadless cardiac pacemakers and/or an implantable cardioverter defibrillator. In some instances, the leadless cardiac pacing device 20 may communicate using conducted communication techniques and may deliver and/or receive communication signals through one or more of the electrodes (e.g., the electrodes 26-36 or other electrodes). In some embodiments, the leadless cardiac pacing device 20 may include one or more communication wires configured to operate as antenna for wireless communication with and/or to receive electrical energy from one or more other devices.
In some instances, the leadless cardiac pacing device 20 may include a neck portion extending longitudinally from the body 22 to a proximal hub 38 (e.g., a docking hub or other member) disposed generally proximal of the body 22. During implantation, the proximal hub 38 may be releasably coupled to an implantation and/or retrieval device (not shown in
In some instances, the leadless cardiac pacing device 20 may be delivered from a delivery catheter (not shown in
Although the distal extension 24 is depicted in
The distal extension 24 may include a proximal end 24a and a distal end 24b. The distal end 24b of the distal extension 24 may include one or more engaging members, but this is not required. The engaging members, when included, may help secure the distal end 24b of the distal extension 24 within the coronary sinus 15 or the great cardiac vein 17, and/or may include one or more electrodes or wire loops and may act as an antenna to communicate with and/or receive electrical energy from one or more other devices. For example, the leadless cardiac pacing device 20 may receive an energy transfer and/or communicate using inductive and/or conductive communication techniques through electrodes and/or wire loops of the engaging member.
In some embodiments, the electrodes 30-36 on the distal extension 24 may be used to deliver electrical stimulation to the heart 10. For example, the leadless cardiac pacing device 20 may deliver electrical stimulation to the left ventricle 14 of heart 10 through a set of one or more of electrodes (e.g., a set from the electrodes 30-36 or other electrodes). In some embodiments, the leadless cardiac pacing device 20 may deliver electrical stimulation to the left ventricle 14 of the heart 10 using two or more of the electrodes 30-36 either simultaneously or with a delay (e.g. via multi-electrode pacing). In some embodiments, the leadless cardiac pacing device 20 may use one or more of the electrodes 30-36 to communicate with one or more other devices (e.g., the electrodes 30-36 may act as an antenna). For example, the leadless cardiac pacing device 20 may receive an energy transfer and/or communicate using inductive or conductive communication techniques through one or more of the electrodes 30-36.
The electrodes 26-36 and/or other electrodes on the leadless cardiac pacing device 20 may be able to sense electrical signals, provide electrical stimulation signals, or sense electrical signals and provide electrical stimulation signals. Signal processing, communication, and/or therapy pulse generation may take place at any portion of the leadless cardiac pacing device where the appropriate processing modules may be located.
In one example, signal processing, communication, and therapy pulse generation for the electrodes (e.g., electrodes 26-36 and/or other electrodes) of the leadless cardiac pacing device 20 may take place in modules within or supported by the body 22.
In some embodiments, the leadless cardiac pacing device 20 may be implanted as a single device (e.g., without additional leadless cardiac pacing devices or one or more implantable cardioverter defibrillators), which may provide electrical stimulation to the right atrium 11, the left atrium 12, right ventricle 13, and/or the left ventricle 14, as desired. For example, the leadless cardiac pacing device 20 may be configured to deliver electrical stimulation in accordance with a therapy program to treat atrial fibrillation or atrial flutter. In other cases, the leadless cardiac pacing device 20 may be implanted with other leadless cardiac pacing devices and/or one or more implantable cardioverter defibrillators implanted at one or more locations in and/or around the heart 10.
As discussed above, the leadless cardiac pacing device 20 may have one or more electrodes, such as electrodes 26, 28 and/or other electrodes, which in the example shown, are supported by the body 22 as described herein. It is contemplated in some cases that the body 22 may have a different number of electrodes, or no electrodes at all.
In some embodiments, the leadless cardiac pacing device 20 may include a neck portion 46 extending from a proximal end of the body 22 to the proximal hub 38. In some cases, the neck portion 46 may have a first outer extent and a proximal end of the neck portion 46 may be connected to the proximal hub 38 having a second outer extent. In some examples, the second outer extent of the proximal hub 38 may be greater than the first outer extent of the neck portion 46. Other configurations are also contemplated.
During implantation, as discussed in greater detail below with respect to
In some instances, the body 22 may include the fixation member 50 and/or the fixation member 50 may extend from the body 22 opposite the proximal hub 38. In some embodiments, the fixation member 50 may be a helical fixation member and may include a distal tip 57, as depicted in
The fixation member 50 may be secured to the body 22 in any suitable manner. In one example, a proximal portion of the fixation member 50 (e.g., a proximal portion of the helical coil) may be embedded (e.g., molded) within the body 22 and a distal portion (e.g., a distal portion of the helical coil) of the fixation member 50 may extend from the body 22 and may be configured to engage cardiac tissue of the patient when the leadless cardiac pacing device is positioned in the patient. The distal portion of the fixation member 50 may be configured to extend about 0.5 revolutions to about 2.0 revolutions (or any amount therebetween) about the body 22. The fixation member 50 may be configured, at least in part, from a material that is configured to penetrate and engage tissue of a heart, that is electrically conductive, that is radiopaque, and/or that is flexible and/or has shape memory properties. Some suitable but non-limiting examples of materials for the fixation member 50 are described below.
In some cases, the fixation member 50 may be able to straighten or elongate from the helical configuration when the fixation member 50 is engaging tissue and an axial force is applied to the leadless cardiac pacing device 20. In some instances, the fixation member 50 may be plastically deformed and elongated into a straightened configuration from its helical configuration when subjected to an axial force. Such a configuration of the fixation member 50 may facilitate removal of the leadless cardiac pacing device 20 and may reduce risk causing damage to the patient due to perforation or bruising.
Although one fixation member 50 is depicted on the body 22 in the Figures, the body 22 may support one or more additional fixation members that are axially spaced from the fixation member 50. In other instances, the body 22 may not include a fixation member 50. In some cases, as discussed above, the fixation member 50 may include or form one or more electrodes (e.g., the second electrode 28 or other suitable electrode) and/or may act as an antenna to communicate with and/or receive electrical energy from one or more other devices. For example, the leadless cardiac pacing device 20 may receive an energy transfer and/or communicate using inductive and/or conductive communication techniques through electrodes of the fixation member 50.
In at least some cases, the body 22 may have a guide wire port 54 extending through and/or opening out to a side of the body 22, where the side extends from a first end to a second end of the body 22. In some cases, the guide wire port 54 may be configured to receive a guide wire. Where the leadless cardiac pacing device 20 includes the distal extension 24, the distal extension 24 may include a corresponding guide wire port at a distal tip of the distal end 24b of the distal extension 24. In such instances, a guide wire may be placed down the great cardiac vein 17 (or other vessel in communication with the coronary sinus 15). The leadless cardiac pacing device 20 may be tracked over the guide wire by threading the distal extension 24 over a proximal end of the guide wire, and then advancing the leadless cardiac pacing device 20 over the guide wire until in position. In embodiments where the leadless cardiac pacing device 20 does not include the distal extension 24, the body 22 may include a second guide wire port.
When included, the distal extension 24 may extend from the body 22 at any suitable angle. In some cases, the distal extension 24 may extend from the body 22 at an angle relative to a central longitudinal axis of the body 22. In some embodiments, the angle may be an oblique angle, such that the distal extension 24, while in an unconstrained state with no external forces applied to bend or flex the distal extension 24, extends from the body 22 at a non-parallel angle to the central longitudinal axis of the body 22. In some instances, the oblique angle may be in the range of 10 degrees to 50 degrees. In some cases, the distal extension 24 may extend distally from the body 22 toward a circumferential side of the body 22 opposite from the guide wire port 54.
The distal extension 24 may be a thin, elongated, and flexible member, particularly in relation to the body 22. For instance, the distal extension 24 may be between two and ten times the length of the body 22. In some embodiments, the electrodes 30-36 and/or other electrodes may be disposed proximate the distal end 24b of the distal extension 24 or may be spread out along the length of distal extension 24 (e.g., longitudinally spaced from one another), as shown in
A system 100 may include a first elongate shaft 104 including a lumen extending therethrough and extending distally from a proximal handle 102. The first elongate shaft 104 may be a tubular member and/or may be annular with a wall defining the lumen extending therethrough. The first elongate shaft 104 may be slidably disposed within the lumen of the catheter 80. The proximal handle 102 may include one or more actuation elements 106 configured to deflect and/or steer a distal end of the first elongate shaft 104, from side to side for example. In one example configuration, movement and/or translation (e.g., longitudinal, rotational, etc.) of the one or more actuation elements 106 may change tension characteristics applied to the first elongate shaft 104, such as by a pull wire or other suitable means. Other means of steering the first elongate shaft 104 are also contemplated. Some suitable, but non-limiting, examples of materials for the proximal handle 102, the first elongate shaft 104, and/or the one or more actuation elements 106 are discussed below.
In some embodiments, the system 100 may include an elongate member 108 slidably disposed within the lumen of the first elongate shaft 104. In
In some embodiments, the system 100 may include one or more irrigation ports. In one example, the system 100 may include a first irrigation port 110 fluidly connected to the proximal handle 102 and configured to irrigate and/or flush the lumen of the first elongate shaft 104. With the elongate member 108 in place within the lumen of the first elongate shaft 104, the first irrigation port 110 may be configured to irrigate and/or flush between an outer surface of the elongate member 108 and an inner surface of the lumen of the first elongate shaft 104. In some embodiments, the system 100 may include a second irrigation port 112 fluidly connected to the elongate member 108 and configured to irrigate and/or flush the lumen of the elongate member 108. In at least some embodiments, both the first irrigation port 110 and the second irrigation port 112 may be present and/or utilized. In some embodiments, neither of the first irrigation port 110 and the second irrigation port 112 may be present and/or utilized. Additional and/or other irrigation ports may be added and/or used as needed. In some embodiments, the system 100 may include a proximal port 114. In some embodiments, the proximal port 114 may be and/or may include a sealing structure configured to prevent fluid communication with an interior of the proximal handle 102 and/or the lumen of the first elongate shaft 104, and/or fluid leakage therefrom. Some suitable, but non-limiting, examples of materials for the first irrigation port 110, the second irrigation port 112, and/or the proximal port 114 are discussed below.
The system 100 may include a second elongate shaft 116 slidably disposed within the lumen of the first elongate shaft 104 and/or the elongate member 108. In some embodiments, the second elongate shaft 116 may include a first proximal handle 118 disposed proximal of the proximal port 114 and/or the proximal handle 102. In some embodiments, the second elongate shaft 116 may include a second proximal handle 120 disposed proximal of the first proximal handle 118. In some embodiments, the second proximal handle 120 may be fixedly attached to the second elongate shaft 116 at and/or proximate a proximal end of the second elongate shaft 116. The first proximal handle 118 may be slidable on the second elongate shaft 116 and may selectively lockable to the second elongate shaft 116 at a variable position along the second elongate shaft 116 selected by the user. In some embodiments, locking the first proximal handle 118 to the second elongate shaft 116 may limit axial movement of the second elongate shaft 116 relative to the handle 102, the first elongate shaft 104, the elongate member 108, and/or the proximal port 114. For example, when the first proximal handle 118 is locked to the second elongate shaft 116, the first proximal handle 118 may contact and/or interfere with the proximal port 114 (or a proximal surface of the proximal handle 102 and/or the elongate member 108, where present), thereby preventing further distal translation of the second elongate shaft 116 relative to the handle 102, the first elongate shaft 104, the elongate member 108, and/or the proximal port 114. Additional and/or other reasons for locking the first proximal handle 118 to the second elongate shaft 116 will become apparent. In at least some embodiments, the second elongate shaft 116 may be a tubular member, such as a hypotube or other similar structure, having a lumen extending therethrough. In some embodiments, the second elongate shaft 116 may be a solid shaft or wire devoid of any lumens disposed therein. Some suitable, but non-limiting, examples of materials for the second elongate shaft 116, the first proximal handle 118, and/or the second proximal handle 120 are discussed below.
The system 100 may include an end cap assembly 122 disposed at a distal end of the first elongate shaft 104. In some embodiments, the end cap assembly 122 may include an outer housing 124 fixedly attached to the distal end of the first elongate shaft 104 and an insert 126 secured within the outer housing 124, as shown in
The system 100 may include a plurality of wires 130 attached to the second elongate shaft 116 and extending distally from the end cap assembly 122. While not explicitly shown, the plurality of wires 130 may be attached (e.g., fixedly attached, welded, bonded, etc.) to the second elongate shaft 116 at a location within the lumen of the first elongate shaft 104 and/or the elongate member 108. In some embodiments, the location may be proximate the distal end of the first elongate shaft 104 and/or the elongate member 108. In some embodiments, the location may be along a middle portion (e.g., from about ¼ to about ¾ of an overall length) of the first elongate shaft 104 and/or the elongate member 108. The plurality of wires 130 may be movable relative to the end cap assembly 122 via translation and/or movement of the second elongate shaft 116 relative to the first elongate shaft 104 and/or the elongate member 108. In some embodiments, the plurality of wires 130 may be movable and/or translatable through the end cap assembly 122 between a first position (e.g.,
The plurality of wires 130 may be configured to engage the proximal hub 38 of the leadless cardiac pacing device 20. In some embodiments, the plurality of wires 130 may form a plurality of wire loops 132 distal of and/or extending distally from the end cap assembly 122. In some embodiments, the plurality of wire loops 132 may be translatable between a first position and a second position distal of the first position. In some embodiments, the plurality of wire loops 132 may be configured to engage the proximal hub 38 of the leadless cardiac pacing device 20 in the first position. In some embodiments, the plurality of wire loops 132 may be configured to secure the proximal hub 38 of the leadless cardiac pacing device 20 relative to the end cap assembly 122 in the first position. In some embodiments, the plurality of wire loops 132 may be configured to secure the proximal hub 38 of the leadless cardiac pacing device 20 against the distalmost surface of the insert 126 in the first position. The plurality of bores 128 may be configured to receive the plurality of wires 130. In some embodiments, the plurality of wires 130 may extend through the plurality of bores 128. In some embodiments, the plurality of wires 130 may be movable and/or translatable through the plurality of bores 128 via translation and/or longitudinal movement of the second elongate shaft 116 relative to the first elongate shaft 104 and/or the second proximal handle 120 relative to the first proximal handle 118. In some embodiments, the second proximal handle 120 may be spaced proximally apart from the first proximal handle 118 when the plurality of wires 130 and/or the plurality of wire loops 132 is in the first position (e.g.,
In at least some embodiments, the configuration of
In some embodiments, in the first position, the plurality of wire loops 132 may include three or more intersecting distal end segments 134 forming a bounded opening 136 receiving the neck portion 46 of the leadless cardiac pacing device 20 therethrough. In some embodiments, in the first position, the bounded opening 136 may have a smallest radial extent measured perpendicular to the central longitudinal axis of the end cap assembly 122 that is greater than a greatest radial extent of the neck portion 46 measured perpendicular to the central longitudinal axis of the leadless cardiac pacing device 20, and the bounded opening 136 may have a greatest radial extent measured perpendicular to the central longitudinal axis of the end cap assembly 122 that is less than a smallest radial extent of the proximal hub 38 measured perpendicular to the central longitudinal axis of the leadless cardiac pacing device 20.
In some embodiments, circumferentially adjacent wire loops and/or distal end segments of the plurality of wire loops 132 crisscross (e.g., cross over and/or under) each other when viewed axially along the central longitudinal axis of the end cap assembly 122. In some embodiments, when the plurality of wires 130 and/or the plurality of wire loops 132 is in the first position, circumferentially adjacent wire loops of the plurality of wire loops 132 crisscross (e.g., cross over and/or under) each other when viewed axially along the central longitudinal axis of the end cap assembly 122. In some embodiments, when the plurality of wires 130 and/or the plurality of wire loops 132 is in the second position, circumferentially adjacent wire loops of the plurality of wire loops 132 crisscross (e.g., cross over and/or under) each other when viewed axially along the central longitudinal axis of the end cap assembly 122.
In some embodiments, the plurality of wire loops 132 may include a first wire loop 140 passing through a first pair 142 of the plurality of bores 128. In some embodiments, the plurality of wire loops 132 may include a second wire loop 144 passing through a second pair 146 of the plurality of bores 128. In some embodiments, the plurality of wire loops 132 may include a third wire loop 148 passing through a third pair 150 of the plurality of bores 128. In some embodiments, the plurality of wire loops 132 may include a fourth wire loop 152 passing through a fourth pair 154 of the plurality of bores 128. Other configurations and/or arrangements are also contemplated.
In some embodiments, one of the second pair 146 of the plurality of bores 128 may be disposed circumferentially between the first pair 142 of the plurality of bores 128. In some embodiments, one of the third pair 150 of the plurality of bores 128 may be disposed circumferentially between the second pair 146 of the plurality of bores 128. In some embodiments, one of the fourth pair 154 of the plurality of bores 128 may be disposed circumferentially between the third pair 150 of the plurality of bores 128. In some embodiments, one of the first pair 142 of the plurality of bores 128 may be disposed circumferentially between the fourth pair 154 of the plurality of bores 128. Other configurations and/or arrangements are also contemplated.
In the example of
In some embodiments, the insert 1326 may include a plurality of insert members 1330 (e.g.,
As seen in
Each of the plurality of insert members 1330 may include a first lateral face 1334 and a second lateral face 1336. In some embodiments, the first lateral face 1334 and the second lateral face 1336 may be oriented substantially perpendicular to each other. Other configurations are also possible. The first lateral face 1334 may include a recess 1338 extending into the insert member 1330 and the second lateral face 1336 may include a projection 1340 extending outward therefrom. When the plurality of insert members 1330 are assembled together, the projection 1340 may be received within the recess 1338. For example, the projection 1340 of a first insert member 1330 may be received within the recess 1338 of a second insert member 1330, the projection 1340 of the second insert member 1330 may be received within the recess 1338 of a third insert member 1330, the projection 1340 of the third insert member 1330 may be received within the recess 1338 of a fourth insert member 1330, and the projection 1340 of the fourth insert member 1330 may be received within the recess 1338 of the first insert member 1330. In at least some embodiments, each of the plurality of insert members 1330 may include a distal recess extending proximally from a distally facing surface of the insert member 1330 and configured to receive a portion of the insert member retainer 1332. In some embodiments, the distally facing surface of the insert member 1330 may be substantially parallel to and/or coplanar with the distalmost surface 1327 of the insert member retainer 1332 when the end cap assembly 1322 is fully assembled. As may be seen and/or determined from
In some embodiments, implanting the leadless cardiac pacing device 20 within the heart 10 may begin by positioning a guide wire within heart 10, such as a first guide wire 94 depicted in
In some instances, the first guide wire 94 may have one or more radiopaque markers disposed on and/or adjacent to a distal end of the first guide wire 94. Such radiopaque markers may allow for easier viewing of the first guide wire 94 through one or more medical imaging systems as the first guide wire 94 is maneuvered into position with the heart 10. In some embodiments, the radiopaque markers may be spaced apart from each other by a known distance. In such embodiments, by counting the number of radiopaque markers between two features within the heart 10, a distance may be determined between the two features. In some embodiments, the leadless cardiac pacing device 20 may be manufactured in a variety of sizes, or various portions of the leadless cardiac pacing device 20, such as the body 22 and the distal extension 24, may be manufactured in various sizes and lengths. By determining a distance between different features of the patient's heart 10, for instance between the coronary sinus ostium 16 and the septum 18 in the right atrium 11, as depicted in
After measuring distances between various features of the heart 10, or in embodiments where such measurements are not needed, the catheter 80 (e.g., an introducer) and the dilator 86 may be maneuvered over the first guide wire 94 into the heart 10, as depicted in
The dilator 86 may include a conical tapered tip, such that advancing the catheter 80 and the dilator 86 into the coronary sinus 15 expands the inner diameter of the coronary sinus 15. In another example, the dilator 86 may be rounded or may have a more abrupt taper than a conical taper. Other dilator configurations are contemplated and any configuration suitable for dilating the coronary sinus 15 may be utilized. As such, if the coronary sinus 15 needs to be expanded to receive the leadless cardiac pacing device 20, the distal end or distal tip of the catheter 80 and/or the dilator 86 may be advanced through the ostium 16 of the coronary sinus 15 to dilate the coronary sinus 15 a suitable amount sufficient to receive the leadless cardiac pacing device 20. In addition to or as an alternative to the catheter 80 and/or the dilator 86, one or more other catheters, dilators, or introducers may be used to facilitate dilating, cannulating, and/or otherwise entering the coronary sinus 15.
Once the coronary sinus 15 has been cannulated and the catheter 80 inserted therein, the first guide wire 94 may then be removed from the catheter 80, as depicted in
Once the system 100, the leadless cardiac pacing device 20, and/or the catheter 80 have been position within the coronary sinus 15 adjacent a target location, the system 100, the first elongate shaft 104, and/or the leadless cardiac pacing device 20 may be rotated to position the distal tip 57 of the fixation member 50 at a desired location for puncturing and engaging tissue of the heart 10 and/or the coronary sinus 15. An orientation of the leadless cardiac pacing device 20 within the coronary sinus 15 and/or within the system 100 may be adjusted via interacting with a proximal end of the system 100 and/or may be adjusted in a different suitable manner. In some cases, the orientation of the leadless cardiac pacing device 20 within the coronary sinus 15 and/or within the system 100 may be adjusted by adjusting a position of the leadless cardiac pacing device 20 in a longitudinal direction and/or by rotating the leadless cardiac pacing device 20 in a direction of arrow A and/or arrow B using the system 100 and/or aspects thereof.
In some cases, a rotational and/or longitudinal position of the distal tip 57 may be known or identifiable from one or more radiopaque markers and the known rotational and/or longitudinal position may be utilized for positioning the distal tip 57. In one example, the distal tip 57 may be or may include a radiopaque marker identifiable by one or more imaging systems to facilitate proper alignment of the distal tip 57 of the fixation member 50 with the tissue of the heart 10 and/or the coronary sinus 15. Alternatively or additionally, the fixation member 50 may include one or more other radiopaque features and/or the leadless cardiac pacing device 20 may include one or more radiopaque markers having a known relationship with the distal tip 57 that may be used to position the distal tip 57 at the desired location. In one example, the distal tip 57 may have a first circumferential position, a tail of the fixation member 50 may have a second circumferential position at a predetermined angular orientation from the first circumferential position that may be used to facilitate rotationally aligning the distal tip 57 with target tissue of the heart. Rotation of the leadless cardiac pacing device 20 to rotationally align the distal tip 57 with target tissue of the heart may be performed while the distal tip 57 remains within the lumen of the catheter 80 to prevent unintentional penetration of the distal tip 57 into the tissue, and thereafter the fixation member 50 may be deployed out of the distal end of the catheter 80. Alternatively or additionally, the leadless cardiac pacing device 20 may be rotated in a counter direction of the helical anchor of the fixation member 50 after deploying the distal tip 57 of the fixation member 50 out of the distal end of the catheter 80 to prevent unintentional penetration of the distal tip 57 into the tissue.
Once the leadless cardiac pacing device 20 is in position, the catheter 80 and the second guide wire 96 may be retracted and the leadless cardiac pacing device 20 may be further rotated using the first elongate shaft 104 (e.g., in the direction of arrow A and/or other suitable direction) such that the distal tip 57 and the fixation member 50 engage tissue of the heart 10 and/or the coronary sinus 15. In some instances, the leadless cardiac pacing device 20 may be oriented such that the distal tip 57 initially penetrates into the left atrial muscle and/or through a wall of the coronary sinus 15. Once the fixation member 50 is engaged with the tissue, the system 100 (less the leadless cardiac pacing device 20) and the catheter 80 may be retracted and, optionally, removed from the heart 10.
In some cases, the implanted leadless cardiac pacing device 20 may be removed from the coronary sinus 15 and/or the positioning of the implanted leadless cardiac pacing device 20 may be adjusted.
In addition to or as an alternative to rotating the leadless cardiac pacing device 20 in the direction of arrow B, a longitudinal and/or axial force may be applied to the leadless cardiac pacing device 20 in a direction of arrow C (e.g., a longitudinal direction). When the fixation member 50 is still engaged with the tissue of the heart, applying the longitudinal and/or axial force to the leadless cardiac pacing device 20 in the longitudinal direction of arrow C may cause the fixation member 50 to elongate (e.g., straighten and/or elongate in one or more other suitable manners), as shown in
After the fixation member 50 has been completely removed from the tissue of the heart 10 as shown in
In some cases, the catheter 80 may be inserted into the vasculature of the patient (e.g., into the coronary sinus 15) and positioned over at least part of the leadless cardiac pacing device 20 and/or the retrieval device 78 (e.g., the system 100) to facilitate withdrawing the leadless cardiac pacing device 20 from the coronary sinus 15. In such cases, the catheter 80 may be positioned at a location covering a proximal end of the leadless cardiac pacing device 20 and the retrieval device 78 (e.g., the system 100) may be advanced through the catheter 80 to the leadless cardiac pacing device 20 at least partially covered by the catheter 80. The positioning of the catheter 80 over the proximal end of the leadless cardiac pacing device 20 may include deflecting a distal end portion of the catheter 80 into the coronary sinus 15 and steering the catheter 80 over the proximal end of the leadless cardiac pacing device 20. The deflection and steering of the catheter 80 may be effected by manipulating one or more control features adjacent a proximal end of the catheter 80 and/or the catheter 80 may have a pre-formed bend configured to bend toward the coronary sinus 15. In some embodiments, the leadless cardiac pacing device 20 may be removed using only the retrieval device 78 (e.g., the system 100) without the presence of the catheter 80.
Those skilled in the art will recognize that the present disclosure may be manifested in a variety of forms other than the specific embodiments described and contemplated herein. For instance, as described herein, various embodiments include one or more modules described as performing various functions. However, other embodiments may include additional modules that split the described functions up over more modules than that described herein. Additionally, other embodiments may consolidate the described functions into fewer modules.
The materials that can be used for the various components of the system(s) and the various elements thereof disclosed herein may include those commonly associated with medical devices. For simplicity purposes, the following discussion refers to the system. However, this is not intended to limit the devices and methods described herein, as the discussion may be applied to other elements, members, components, or devices disclosed herein, such as, but not limited to, the first elongate shaft, the second elongate shaft, the end cap assembly, the outer housing, the insert, the plurality of wires, the leadless cardiac pacing device, the handle(s), and/or elements or components thereof.
In some embodiments, the system, and/or components thereof, may be made from a metal, metal alloy, polymer (some examples of which are disclosed below), a metal-polymer composite, ceramics, combinations thereof, and the like, or other suitable material.
Some examples of suitable polymers may include polytetrafluoroethylene (PTFE), ethylene tetrafluoroethylene (ETFE), fluorinated ethylene propylene (FEP), polyoxymethylene (POM, for example, DELRIN® available from DuPont), polyether block ester, polyurethane (for example, Polyurethane 85A), polypropylene (PP), polyvinylchloride (PVC), polyether-ester (for example, ARNITEL® available from DSM Engineering Plastics), ether or ester based copolymers (for example, butylene/poly(alkylene ether) phthalate and/or other polyester elastomers such as HYTREL® available from DuPont), polyamide (for example, DURETHAN® available from Bayer or CRISTAMID® available from Elf Atochem), elastomeric polyamides, block polyamide/ethers, polyether block amide (PEBA, for example available under the trade name PEBAX®), ethylene vinyl acetate copolymers (EVA), silicones, polyethylene (PE), Marlex high-density polyethylene, Marlex low-density polyethylene, linear low density polyethylene (for example REXELL®), polyester, polybutylene terephthalate (PBT), polyethylene terephthalate (PET), polytrimethylene terephthalate, polyethylene naphthalate (PEN), polyetheretherketone (PEEK), polyimide (PI), polyetherimide (PEI), polyphenylene sulfide (PPS), polyphenylene oxide (PPO), poly paraphenylene terephthalamide (for example, KEVLAR®), polysulfone, nylon, nylon-12 (such as GRILAMID® available from EMS American Grilon), perfluoro(propyl vinyl ether) (PFA), ethylene vinyl alcohol, polyolefin, polystyrene, epoxy, polyvinylidene chloride (PVdC), poly(styrene-b-isobutylene-b-styrene) (for example, SIBS and/or SIBS 50A), polycarbonates, polyurethane silicone copolymers (for example, ElastEon® from Aortech Biomaterials or ChronoSil® from AdvanSource Biomaterials), biocompatible polymers, other suitable materials, or mixtures, combinations, copolymers thereof, polymer/metal composites, and the like. In some embodiments the sheath can be blended with a liquid crystal polymer (LCP). For example, the mixture can contain up to about 6 percent LCP.
Some examples of suitable metals and metal alloys include stainless steel, such as 304V, 304L, and 316LV stainless steel; mild steel; nickel-titanium alloy such as linear-elastic and/or super-elastic nitinol; other nickel alloys such as nickel-chromium-molybdenum alloys (e.g., UNS: N06625 such as INCONEL® 625, UNS: N06022 such as HASTELLOY® C-22®, UNS: N10276 such as HASTELLOY® C276®, other HASTELLOY® alloys, and the like), nickel-copper alloys (e.g., UNS: N04400 such as MONEL® 400, NICKELVAC® 400, NICORROS® 400, and the like), nickel-cobalt-chromium-molybdenum alloys (e.g., UNS: R30035 such as MP35-N® and the like), nickel-molybdenum alloys (e.g., UNS: N10665 such as HASTELLOY® ALLOY B2®), other nickel-chromium alloys, other nickel-molybdenum alloys, other nickel-cobalt alloys, other nickel-iron alloys, other nickel-copper alloys, other nickel-tungsten or tungsten alloys, and the like; cobalt-chromium alloys; cobalt-chromium-molybdenum alloys (e.g., UNS: R30003 such as ELGILOY®, PHYNOX®, and the like); platinum enriched stainless steel; titanium; platinum; palladium; gold; combinations thereof; or any other suitable material.
In at least some embodiments, portions or all of the system, and/or components thereof, may also be doped with, made of, or otherwise include a radiopaque material. Radiopaque materials are understood to be materials capable of producing a relatively bright image on a fluoroscopy screen or another imaging technique during a medical procedure. This relatively bright image aids the user of the system in determining its location. Some examples of radiopaque materials can include, but are not limited to, gold, platinum, palladium, tantalum, tungsten alloy, polymer material loaded with a radiopaque filler, and the like. Additionally, other radiopaque marker bands and/or coils may also be incorporated into the design of the system to achieve the same result.
In some embodiments, a degree of Magnetic Resonance Imaging (MRI) compatibility is imparted into the system and/or other elements disclosed herein. For example, the system, and/or components or portions thereof, may be made of a material that does not substantially distort the image and create substantial artifacts (i.e., gaps in the image). Certain ferromagnetic materials, for example, may not be suitable because they may create artifacts in an MRI image. The system, or portions thereof, may also be made from a material that the MRI machine can image. Some materials that exhibit these characteristics include, for example, tungsten, cobalt-chromium-molybdenum alloys (e.g., UNS: R30003 such as ELGILOY®, PHYNOX®, and the like), nickel-cobalt-chromium-molybdenum alloys (e.g., UNS: R30035 such as MP35-N® and the like), nitinol, and the like, and others.
In some embodiments, the system and/or other elements disclosed herein may include and/or be treated with a suitable therapeutic agent. Some examples of suitable therapeutic agents may include anti-thrombogenic agents (such as heparin, heparin derivatives, urokinase, and PPack (dextrophenylalanine proline arginine chloromethylketone)); anti-proliferative agents (such as enoxaparin, angiopeptin, monoclonal antibodies capable of blocking smooth muscle cell proliferation, hirudin, and acetylsalicylic acid); anti-inflammatory agents (such as dexamethasone, prednisolone, corticosterone, budesonide, estrogen, sulfasalazine, and mesalamine); antineoplastic/antiproliferative/anti-mitotic agents (such as paclitaxel, 5-fluorouracil, cisplatin, vinblastine, vincristine, epothilones, endostatin, angiostatin and thymidine kinase inhibitors); anesthetic agents (such as lidocaine, bupivacaine, and ropivacaine); anti-coagulants (such as D-Phe-Pro-Arg chloromethyl keton, an RGD peptide-containing compound, heparin, anti-thrombin compounds, platelet receptor antagonists, anti-thrombin antibodies, anti-platelet receptor antibodies, aspirin, prostaglandin inhibitors, platelet inhibitors, and tick antiplatelet peptides); vascular cell growth promoters (such as growth factor inhibitors, growth factor receptor antagonists, transcriptional activators, and translational promoters); vascular cell growth inhibitors (such as growth factor inhibitors, growth factor receptor antagonists, transcriptional repressors, translational repressors, replication inhibitors, inhibitory antibodies, antibodies directed against growth factors, bifunctional molecules consisting of a growth factor and a cytotoxin, bifunctional molecules consisting of an antibody and a cytotoxin); cholesterol-lowering agents; vasodilating agents; and agents which interfere with endogenous vasoactive mechanisms.
It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the invention. This may include, to the extent that it is appropriate, the use of any of the features of one example embodiment being used in other embodiments. The invention's scope is, of course, defined in the language in which the appended claims are expressed.
This application claims the benefit of and priority to U.S. Provisional Patent Application No. 62/898,701, filed on Sep. 11, 2019 and titled TOOLS AND SYSTEMS FOR IMPLANTING AND/OR RETRIEVING A LEADLESS CARDIAC PACING DEVICE WITH HELIX FIXATION, this disclosure of which is incorporated by reference.
Number | Date | Country | |
---|---|---|---|
62898701 | Sep 2019 | US |